Huge Study Finds Constellation of Health Benefits for Ozempic Beyond Weight Loss
A new study that tracked millions of diabetes patient outcomes over a period of 3.5 years found that those on GLP-1 medications saw significant improvements across a staggering range of health concerns, far beyond anything clearly linked to weight or blood sugar. The patients experienced improvements in addiction and psychotic disorders and the risk of Alzheimer's was decreased. GLP-1RA drugs act on receptors that are expressed in brain areas involved in impulse control, reward, and addiction, which may potentially explain their effectiveness in curbing appetite and addiction disorders. While the findings are positive, the researchers found some issues that seemed to be exacerbated by taking GLP-1s, including an increase in risk for arthritis and pancreatitis.